NYC’s top re­search in­sti­tu­tions part­ner on Step 2 in build­ing a biotech hub

A trio of New York’s best known re­search in­sti­tu­tions have al­lied with Take­da and a pair of biotech in­vestors to start up a new com­pa­ny that will car­ry some promis­ing new pro­grams in­to clin­i­cal de­vel­op­ment.

Memo­r­i­al Sloan Ket­ter­ing Can­cer Cen­ter, The Rock­e­feller Uni­ver­si­ty and Weill Cor­nell Med­i­cine part­nered with the re­struc­tur­ing Take­da along with Bay City Cap­i­tal and Deer­field Man­age­ment to cre­ate Bridge Med­i­cines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER